ID   C3.6
AC   CVCL_J983
SY   HB4a-C3.6
DR   PRIDE; PXD004195
DR   Wikidata; Q54808132
RX   PubMed=9935193;
RX   PubMed=16685446;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; 3430; ERBB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Deep proteome analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J982 ! HB4a
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
RX   PubMed=9935193; DOI=10.1002/(SICI)1097-0215(19990129)80:3<477::AID-IJC23>3.0.CO;2-W;
RA   Harris R.A., Eichholtz T.J., Hiles I.D., Page M.J., O'Hare M.J.;
RT   "New model of ErbB-2 over-expression in human mammary luminal
RT   epithelial cells.";
RL   Int. J. Cancer 80:477-484(1999).
//
RX   PubMed=16685446; DOI=10.3892/ijo.28.6.1441;
RA   dos Santos M.L., Palanch C.G., Salaorni S., da Silva W.A. Jr.,
RA   Nagai M.A.;
RT   "Transcriptome characterization of human mammary cell lines expressing
RT   different levels of ERBB2 by serial analysis of gene expression.";
RL   Int. J. Oncol. 28:1441-1461(2006).
//